Donation

Established by the International Myeloma Foundation (IMF) at a meeting in Singapore in 2011, the Asian Myeloma Network® (AMN) is the first of its kind in the region and is comprised of myeloma experts from China, Hong Kong, Malaysia, Taiwan, Japan, Philippines, Singapore, South Korea, Vietnam, and Thailand. The AMN has taken the lead in projects to assist IMF in providing physician education and patient support throughout Asia. Since its founding, the AMN has: created a unified database to assess the incidence of myeloma in Asian countries as a basis for establishing region-specific treatment management tools and strategies; launched and overseen clinical trials; enabled myeloma patients to gain access to the newest myeloma treatments; developed informational resource materials in local languages, especially for patients and caregivers; and engaged in collaborative studies.


Asian Myeloma Network (AMN) History

On March 17, 2011, the International Myeloma Foundation (IMF) established the Asian Myeloma Network (AMN) at a meeting in Singapore. Comprised of myeloma experts from China, Hong Kong, Malaysia,Taiwan, Japan, South Korea, Singapore, and Thailand, the IMF Asian Myeloma Network — the first of its kind in the region — has taken the lead in projects to assist IMF in providing physician education and patient support throughout Asia. Myeloma is a growing health problem in Asia, with an incidence that is approaching that in Western countries, but with a much larger population base.

Since its founding, the AMN has:

  • Created a unified database to assess the incidence of myeloma in Asian countries as a basis for establishing region-specific treatment management tools and strategies.
  • Launched and overseen clinical trials.
  • Enabled myeloma patients to gain access to the newest myeloma treatments.
  • Developed informational resource materials in local languages, especially for patients and caregivers.
  • Engaged in collaborative studies.


Executive Committee

Wee Jo Chng

Wee Joo Chng, MD  — Chairperson of the AMN Executive Committee

Dr. Wee Joo Chng has been a Senior Consultant at the National University Cancer Institute, Singapore, part of the National University Health System, for almost two decades. He is an esteemed researcher in genomics, therapeutics and hematologic malignancies, with extensive experience in clinical practice, administration, and leadership. Dr. Chng is currently the Yong Loo Lin Professor in Medical Oncology, Vice President (Biomedical Sciences Research), and Senior Principal Investigator of the Cancer Science Institute of Singapore, at the National University of Singapore.

  • Masahiro Abe
  • Priscilla B. Caguioa
  • Wenming Chen
  • James Chim
  • Gin Gin Gan
  • Hiroshi Handa
  • Jeffrey Huang
  • Shinsuke Iida
  • Hou Jian
  • Jin Soek Kim
  • Kihyun Kim
  • Pankaj Malhotra
  • Chandramouli Nagarajan
  • Teeraya Puavilai
  • Sen Mui Tan
  • Rosalio P. Torres
  • Uday Yanamandra


Executive Staff

  • Daniel Navid
  • Lisa Paik

 

AMN Roster
Name Country Institution
Takeshi Harada Tokushima University Japan Japan Tokushima University
Yutaka Hattori Keio University Faculty of Pharmacy Japan Japan Keio University Faculty of Pharmacy
Haiyan He Shanghai Changzheng Hospital China China Shanghai Changzheng Hospital
Aili He The Second Affiliated Hospital of Xi'an Jiaotong University China China The Second Affiliated Hospital of Xi'an Jiaotong University
Jingsong He First Affiliated Hospital of Medical College, Zhejiang University China China First Affiliated Hospital of Medical College, Zhejiang University
Tran Thi Hong Vietnam Vietnam
Yu-ich Horigome Japan Japan
Naoki Hosen Osaka Univ. Graduate School of Medicine Japan Japan Osaka Univ. Graduate School of Medicine
Jian Hou Ren Ji Hospital China China Ren Ji Hospital
Jeffrey Huang National Taiwan University Hospital Taiwan Taiwan National Taiwan University Hospital
Beihui Huang The First Affiliated Hospital, Sun Yat-sen University China China The First Affiliated Hospital, Sun Yat-sen University
Xiaojun Huang Institute of Peking University China China Institute of Peking University
Yu-Chin Hung National Taiwan University Hospital Taiwan Taiwan National Taiwan University Hospital
Kim Hyo Jung Hallym University Sacred Heart Hospital , Anyang South Korea South Korea Hallym University Sacred Heart Hospital , Anyang
Kong Jee Hyun Wonju Severance Christian Hospital, Yonsei University College of Medicine South Korea South Korea Wonju Severance Christian Hospital, Yonsei University College of Medicine
Michiko Ichi Osaka University Graduate School of Medicine Japan Japan Osaka University Graduate School of Medicine
Shinsuke Iida Nagoya City University Japan Japan Nagoya City University
Sho Ikeda Akita University Graduate School of Medicine Japan Japan Akita University Graduate School of Medicine
Takashi Ikeda Shizuoka Cancer Center Japan Japan Shizuoka Cancer Center
Yoichi Imai Dokkyo Medical University Japan Japan Dokkyo Medical University
Hirono Iriuschishima National Hospital Organization Shibukawa Medical Center Japan Japan National Hospital Organization Shibukawa Medical Center
Tadao Ishida Japanese Red Cross Medical Center Japan Japan Japanese Red Cross Medical Center
Shigeki Ito Iwate Medical University Japan Japan Iwate Medical University
Aditya Jandial India India
Hua Jiang Department of Hematology, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai China China Department of Hematology, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai

Give Where Most Needed